The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Given the paraytec gizmo was designed for more than Sepsis it could be worth anything to the right company. I dont thing 10x more than Phasefocus is an over estimate which equates to 30p + a share. I'm staying in till its sold.
Yes and look at who started this talk of a Special Dividend
Could it be that the gruesome twosome are somehow related to the main man or worst still, the one and only?
Nothing to back up all the promises
All the dividends just the illusion, reality is swift all shares from here to Argo, never looking back what is Trevor promising, remember he just making himself loaded. Good luck to all
If £5million for phasefocus is the going rate I think woodyjohn prediction/hope for a £1billion sale of paraytec is now in perspective.
Disappointed with the news today,thought phasefocus was a better prospect.
Either 1.7p dividend or keeps the wolf from the door for a while longer.
On what????
FAKE news
Agree with you clogs
i cant see how they can disribute ANY proceeds as they have no distributable reserves and this sale just adds to the deficit on reserves
£2.1 M as a dividend i calculate as 3.3p per share held.
The other option would be for us to put that money into several other plcs , which are at attractive prices currently.
Yes please
Castle
It sounds as though the sale will represent a write down of £550,000 for Braveheart.
Special dividend with £2 to distribute, what's that per share 1p...,? Not good...
Pathetic
Obviously a bad investment all round really is that the first offer????
How's it likely to affect the SP? I was in for the last "special dividend" but doubt this one will be quite as profitable.
Did I read that right.. £2m..3p a share ffs..
Back to bed
And remember it has more uses than just sepsis. It wasn't originally designed for that.
Illuminating, thank you.
From the description below it would appear that every hospital in the country /Europe needs one of Paraytec ‘s machines. Interesting!
There is increasing interest in the the development of diagnostics for people with blood-borne bacterial infections. If left untreated, patients will develop sepsis - an acute and life-limiting physiological response which arises from inflammatory signals generated by the immune system. These signals emerge as neutrophils - specialised white blood cells - try to contain the infection, which they do by committing suicide and in so doing extruding their DNA and cellular content to generate a physical net or trap that catches and kills infecting bacteria.
For clinicians, people with blood with blood-borne infections present two challenges:-
(i) what is the nature of the infection (bacteraemia) and how to bring it under control, and
(ii) whether an infection will precipitate sepsis, requiring acute treatment to ensure the patient can avoid septic shock and survive long enough to allow for (i) to happen.
When clinicians suspect bacteraemia, the major challenge is concerned with diagnosis and identification of the infectious species, which determines the nature of antibiotic treatment required. At present, this takes up to 48h and involves lengthy culture of blood samples to enable specific identification of the bacteria present.
The recent reports of tests for sepsis (https://www.independent.co.uk/news/health/sepsis-blood-test-fast-nhs-b2465476.html)are specfically designed to detect the traps set by dying neutrophils, enabling clinicians to treat the life-threatening aspects of sepsis which include a sudden drop in blood pressure, blood-clotting, blood vessel damage and tissue/organ failure. These tests are complementary to the approach adopted by Paraytec Ltd , and allow clinicians to address (ii) but do nothing to address (i).
The Paraytec test is designed to address the issue outlined in (i), using molecular diagnostics and highly sensitive optical imaging to detect the presence of bacteria in samples obtained from blood without prior culture, and to distinguish Gram + from Gram - bacteria. Knowing the Gram status of organisms allows clinicians to make key decisions about antibiotic selection, as well as to suggest the source of infection enabling additional interventional measures.
Sepsis is a horrifying condition, so any company showing any success in its treatment is to be applauded. As Woody says it is difficult to even get to a ballpark figure as to value, but I hope word is getting out that there is a for sale sign up and many interested parties have their calculators humming.
The S.P is reflective of worth and sentiment from those who want to invest here,
Most of the trades are sells and therefore, some are seeing this grind to a halt, with no real sign of progress.
Year's of false promises have done the real damage here.
Schlum, I have asked this question several times, but never had an answer, I admit i wouldn’t have any idea where to start evaluating it’s worth, but i would love to know, even just a ballpark estimate, come on someone must have an answer. ?
GLA
It might be the case that T.B is no longer chasing missing boats after all the money he's already made, I'm sure he could sit back and happily keep things exactly the way they are.
After all, he's nothing to lose
Paraytec.. value. Any realistic estimates as to value.
Competition is health !! The fact is ours does a lot more types of testing we are also more advanced in conclusion and trials and is already for sale , we are a investment company with hopefully dividends, let's see the end result and out come of the CX300 + we have some really good investments that we will sell , many good investment spread under one roof .
Castle
Ref chavitravi - volition diagnostics
I just think TB going to miss the boat on this one unless it goes into overdrive now